Paper · 41997697

Measuring and appraising placebo effects in clinical trials: contemporary challenges and approaches in psychiatry.

Taylor JJ and 13 others. Lancet Psychiatry, 2026. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Measuring and appraising placebo effects in clinical trials: contemporary challenges and approaches in psychiatry. Papers, record 41997697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997697

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Measuring and appraising placebo effects in clinical trials: contemporary challenges and approaches in psychiatry.; PubMed
Journal: Lancet Psychiatry; PubMed
Year: 2026; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/41997697/; PubMed
DOI: https://doi.org/10.1016/s2215-0366(26)00018-0; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13326907/; PubMed
The journal: https://conductscience.org/library/journal-index/101638123; PubMed
Citations, by iCite: 2; iCite
Revised in PubMed: 2026-08-13; PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Taylor JJ	Joseph J
2	Szigeti B	Balázs
3	Silverberg ND	Noah D
4	Ahmadzad-Asl M	Masoud
5	Kare M	Marina
6	Webler R	Ryan
7	Orsini DK	Diana K
8	Rosenblat JD	Joshua D
9	Bschor T	Tom
10	Baethge C	Christopher

1 to 10 of 14Source PubMed

See all 14 authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Placebo Effect	Major topic
Psychiatry	Major topic
Mental Disorders	Major topic
Randomized Controlled Trials as Topic	Major topic
Clinical Trials as Topic	Major topic
Humans
Nocebo Effect
Research Design

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
K23 MH129829	NIMH NIH HHS	United States	K23MH129829	PubMed

Source NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References135

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	29,955,803	Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial.	JAMA Psychiatry	2018	https://conductscience.org/library/papers/29955803	PubMed
2	18,580,816	Sham electroconvulsive therapy studies in depressive illness: a review of the literature and consideration of the placebo phenomenon in electroconvulsive therapy practice.	J ECT	2009	https://conductscience.org/library/papers/18580816	PubMed
3	16,452,103	Sham device v inert pill: randomised controlled trial of two placebo treatments.	BMJ	2006	https://conductscience.org/library/papers/16452103	PubMed
4	32,141,721	The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration.	J Clin Psychiatry	2020	https://conductscience.org/library/papers/32141721	PubMed
5	33,852,780	Trial of Psilocybin versus Escitalopram for Depression.	N Engl J Med	2021	https://conductscience.org/library/papers/33852780	PubMed
6	34,861,421	A systematic review and meta-analysis of the success of blinding in antidepressant RCTs.	Psychiatry Res	2022	https://conductscience.org/library/papers/34861421	PubMed
7	24,594,678	Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.	J Nerv Ment Dis	2014	https://conductscience.org/library/papers/24594678	PubMed
8	11,986,125	The functional neuroanatomy of the placebo effect.	Am J Psychiatry	2002	https://conductscience.org/library/papers/11986125	PubMed
9	19,344,914	Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy.	J Psychiatr Res	2009	https://conductscience.org/library/papers/19344914	PubMed
10	21,536,837	Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions.	Psychosom Med	2011	https://conductscience.org/library/papers/21536837	PubMed

1 to 10 of 135

See all 135 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMID	Title	Journal	Year	In Papers
42,827,697	A novel provocation protocol to identify nocebo effects in clinical practice-a proof-of-concept n-of-1 study.	Front Pharmacol	2026	https://conductscience.org/library/papers/42827697

Source PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41997697

GET https://conductscience.org/api/papers/v1/41997697/references?page=2

API reference For AI assistants